ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹16 Cr | ₹12 Cr | ₹14 Cr | ₹26 Cr | ₹27 Cr |
What is the latest Total Non-Current Liabilities ratio of ALBERT DAVID ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹16 Cr |
Mar2023 | ₹12 Cr |
Mar2022 | ₹14 Cr |
Mar2021 | ₹26 Cr |
Mar2020 | ₹27 Cr |
How is Total Non-Current Liabilities of ALBERT DAVID Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹16 Cr | 34.17 | |
Mar2023 | ₹12 Cr | -17.53 | |
Mar2022 | ₹14 Cr | -43.56 | |
Mar2021 | ₹26 Cr | -4.59 | |
Mar2020 | ₹27 Cr | - |
Compare Total Non-Current Liabilities of peers of ALBERT DAVID
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALBERT DAVID | ₹491.0 Cr | 4% | 4.3% | -28% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,176.0 Cr | -0.3% | -2.9% | 11.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,076.0 Cr | 0.7% | 7.4% | 48.1% | Stock Analytics | |
CIPLA | ₹121,592.0 Cr | -0.1% | 0.2% | -2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹113,615.0 Cr | 3.2% | 10.3% | 11.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,024.0 Cr | 2.3% | -0.5% | 13.8% | Stock Analytics |
ALBERT DAVID Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALBERT DAVID | 4% |
4.3% |
-28% |
SENSEX | -1.3% |
-0.3% |
5.8% |
You may also like the below Video Courses